Production (Stage)
Eton Pharmaceuticals, Inc.
ETON
$14.30
-$0.21-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -93.83% | 73.49% | 208.29% | -166.70% | 69.51% |
| Total Depreciation and Amortization | 332.91% | 9.23% | 45.55% | 51.74% | 9.86% |
| Total Amortization of Deferred Charges | 1,076.00% | 4,386.96% | -2.50% | -16.90% | -13.79% |
| Total Other Non-Cash Items | 181.17% | 4.28% | -1.10% | 7.01% | -3.78% |
| Change in Net Operating Assets | 99.86% | -254.86% | 161.91% | 106.86% | -137,900.00% |
| Cash from Operations | 184.51% | -297.67% | 238.14% | -82.33% | -59.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -947.74% | -- | -- | -- |
| Cash from Investing | -- | -4,820.26% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 0.00% | 0.00% | -- |
| Issuance of Common Stock | 5,528.57% | 8,980.22% | -100.00% | 20.71% | -94.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 204.23% | 11,519.05% | -4.34% | 11.84% | -671.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 152.48% | -680.79% | 409.33% | -84.85% | -196.37% |